New developments in genetics of myositis

Current Opinion in Rheumatology

Volumn 28, Issue 6, 2016, Pages 651-656

  Rothwell, Simon ^a   Lamb, Janine A ^a   Chinoy, Hector ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Genetics; Human leukocyte antigen; Idiopathic inflammatory myopathies

Indexed keywords

AMINO ACID; BLK PROTEIN; HLA ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN; STAT4 PROTEIN; UBE2L3 PROTEIN; UNCLASSIFIED DRUG;

DERMATOMYOSITIS; GENETIC ASSOCIATION; GENETIC RISK; GENETICS; HAPLOTYPE; HLA SYSTEM; HUMAN; INCLUSION BODY MYOSITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; AUTOIMMUNE DISEASE; GENETIC PREDISPOSITION; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; MYOSITIS; RISK FACTOR;

AUTOIMMUNE DISEASES; DERMATOMYOSITIS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HLA ANTIGENS; HUMANS; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; RISK FACTORS;

EID: 84979997674     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000328     Document Type: Review

References (33)

1. Price P, Witt C, Allcock R, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167:257-274.
2. Candore G, Lio D, Colonna Romano G, et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002; 1:29-35.
3. Miller FW, Cooper RG, Vencovsky J, et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum 2013; 65:3239-3247.
4. Miller FW, Chen W, O'Hanlon TP, et al. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun 2015; 16:470-480.
5. Rothwell S, Cooper RG, Lundberg IE, et al. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis 2016; 75:1558-1566.
6. Raychaudhuri S, Sandor C, Stahl Ea, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44:291-296.
7. Goyette P, Boucher G, Mallon D, et al. High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nat Genet 2015; 47:172-179.
8. Okada Y, Han B, Tsoi LC, et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. Am J Hum Genet 2014; 95:162-172.
9. O'Hanlon TP, Carrick DM, Targoff IN, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1, and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006; 85:111-127.
10. Chinoy H, Li CKC, Platt H, et al. Genetic association study of NF-kB genes in UK caucasian adult and juvenile onset idiopathic inflammatory myopathy. Rheumatology 2012; 51:794-799.
11. Chinoy H, Salway F, John S, et al. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 2007; 46:1411-1416.
12. Scott AP, Laing NG, Mastaglia F, et al. Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis. J Neuroimmunol 2012; 250:66-70.
13. Lintner KE, Patwardhan A, Rider LG, et al. Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis. Ann Rheum Dis 2015; doi:10.1136/an-nrheumdis-2015-207762. [Epub ahead of print]
14. Furuya T, Hakoda M, Tsuchiya N, et al. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J Rheumatol 2004; 31:1768-1774.
15. Gao X, Han L, Yuan L, et al. HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population. BMC Dermatol 2014; 14:9.
16. Okada Y, Kim K, Han B, et al. Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 2014; 23:6916-6926.
17. Jani M, Massey J, Wedderburn LR, et al. Genotyping of immune-related genetic variants identifies TYK2 as a novel associated locus for idiopathic inflammatory myopathies. Ann Rheum Dis 2014; 73:1750-1752.
18. Kirino Y, Remmers EF. Genetic architectures of seropositive and seronegative rheumatic diseases. Nat Rev Rheumatol 2015; 11:401-414.
19. Yang J, Lee SH, Goddard ME, et al. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011; 88:76-82.
20. Chen S, Wang Q, Wu CY, et al. A single-nucleotide polymorphism of CCL21 rs951005 T/C is associated with susceptibility of polymyositis and such patients with interstitial lung disease in a Chinese Han population. Clin Exp Rheumatol 2015; 33:639-646.
21. Chen S, Wu W, Li J, et al. Single nucleotide polymorphisms in the FAM167A-BLK gene are associated with polymyositis/dermatomyositis in the Han Chinese population. Immunol Res 2015; 62:153-162.
22. Wang Q, Chen S, Li Y, et al. Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han. Immunol Res 2016; 64:204-212.
23. Chen S, Wang Q, Wu Z, et al. Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis/dermatomyositis in Chinese Han population. PLoS One 2014; 9:e110044.
24. Sugiura T, Kawaguchi Y, Goto K, et al. Positive association between STAT4 polymorphisms and polymyositis/dermatomyositis in a Japanese population. Ann Rheum Dis 2012; 71:1646-1650.
25. Sugiura T, Kawaguchi Y, Goto K, et al. Association between a C8orf13-BLK polymorphism and polymyositis/dermatomyositis in the Japanese population: an additive effect with STAT4 on disease susceptibility. PLoS One 2014; 9:e90019.
26. Sivakumar K, Cervenakova L, Dalakas MC, et al. Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy. Ann Neurol 1995; 38:267-269.
27. Garlepp MJ, Tabarias H, van Bockxmeer FM, et al. Apolipoprotein E epsilon 4 in inclusion body myositis. Ann Neurol 1995; 38:957-959.
28. Needham M, Hooper A, James I, et al. Apolipoprotein E alleles in sporadic inclusion body myositis: a reappraisal. Neuromuscul Disord 2008; 18:150-152.
29. Gang Q, Bettencourt C, Machado PM, et al. The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiol Aging 2015; 36:1766.e1-1766.e3.
30. Rothwell S, Cooper RG, Lundberg IE, et al. Largest genetic study to date in sporadic inclusion body myositis confirms the human leukocyte antigen as the most associated region and suggests a role for C-C chemokine receptor type 5. Rheumatology 2016; 55:i48.
31. Weihl CC, Baloh RH, Lee Y, et al. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul Disord 2015; 25:289-296.
32. Gang Q, Bettencourt C, Machado P, et al. Sporadic inclusion body myositis: the genetic contributions to the pathogenesis. Orphanet J Rare Dis 2014; 9:88.
33. Rider LG, Dankó K, Miller FW. Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research. Curr Opin Rheumatol 2014; 26:724-741.